Clinical implications of having reduced mid forced expiratory flow rates (FEF25-75), independently of FEV1, in adult patients with asthma

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Riley, Craig M ^a   Wenzel, Sally E ^b   Castro, Mario ^c   Erzurum, Serpil C ^d   Chung, Kian Fan ^e   Fitzpatrick, Anne M ^f   Gaston, Benjamin ^g   Israel, Elliot ^h   Moore, Wendy C ⁱ   Bleecker, Eugene R ⁱ   Calhoun, William J ^j   Jarjour, Nizar N ^k   Busse, William W ^k   Peters, Stephen P ⁱ   Teague, W Gerald ^l   Sorkness, Ronald ^m   Holguin, Fernando ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j University of Texas Medical Branch School of Medicine   (United States)

^k UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^l UNIVERSITY OF VIRGINIA CHILDREN S HOSPITAL   (United States)

^m UNIVERSITY OF WISCONSIN MADISON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN E; METHACHOLINE; STEROID; BIOLOGICAL MARKER;

ADULT; ARTICLE; ASTHMA; BODY MASS; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DISEASE DURATION; DRUG MEGADOSE; EOSINOPHIL COUNT; ETHNICITY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RESPIRATORY TRACT INFLAMMATION; SENSITIVITY ANALYSIS; SKIN TEST; CLINICAL TRIAL; COMPLICATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; YOUNG ADULT;

ADULT; ASTHMA; BIOMARKERS; BRONCHIAL HYPERREACTIVITY; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; YOUNG ADULT;

EID: 84957552129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145476     Document Type: Article

References (19)

1. Program NAEaP (2007) Expert Panel Report 3. National Heart, Lung and Blood Institute Produced Publications: National Institute of Health.
2. Terra Filho M, Vargas FS, Cukier A, Fiss E, Romeiro Neto M, Croce J, et al. (1986) [Forced mid-expiratory flow rate (FEF 25-75%): a critical analysis of its value in recognizing diseases of the small airways]. Allergol Immunopathol (Madr) 14: 199-203.
3. Perez T, Chanez P, Dusser D, Devillier P (2013) Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction. Respir Med 107: 1667-1674. doi: 10.1016/j.rmed.2013.08.009 PMID: 24025779
4. McFadden ER Jr, Linden DA (1972) A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med 52: 725-737. PMID: 5030170
5. (2007) Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma.
6. Jones SE, Merkle SL, Fulton JE, Wheeler LS, Mannino DM (2006) Relationship between asthma, overweight, and physical activity among U.S. high school students. J Community Health 31: 469-478. PMID: 17186641
7. Quanjer PH, Weiner DJ, Pretto JJ, Brazzale DJ, Boros PW (2014) Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J 43: 1051-1058. doi: 10.1183/09031936.00128113 PMID: 24072211
8. Rao DR, Gaffin JM, Baxi SN, Sheehan WJ, Hoffman EB, Phipatanakul W (2012) The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity. J Asthma 49: 586-592. doi: 10.3109/02770903.2012.690481 PMID: 22742446
9. Jarjour NN, Erzurum SC, Bleecker ER, Calhoun WJ, Castro M, Comhair SA, et al. (2012) Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med 185: 356-362. doi: 10.1164/rccm.201107-1317PP PMID: 22095547
10. (1987) Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 136: 1285-1298. PMID: 3674589
11. Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159: 179-187. PMID: 9872837
12. American Thoracic S, European Respiratory S (2005) ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171: 912-930. PMID: 15817806
13. Sorkness RL, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF, et al. (2008) Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol (1985) 104: 394-403. PMID: 17991792
14. Hankinson JL, Gardner RM (1988) Standardization of spirometry. Am Rev Respir Dis 137: 493-495.
15. Gardner RM, Hankinson JL (1988) Standardization of spirometry - 1987 ATS update (American Thoracic Society). J Occup Med 30: 272-273.
16. Sutherland ER, Martin RJ, Bowler RP, Zhang Y, Rex MD, Kraft M, et al. (2004) Physiologic correlates of distal lung inflammation in asthma. J Allergy Clin Immunol 113: 1046-1050. PMID: 15208583
17. Niimi A, Matsumoto H, Amitani R, Nakano Y, Mishima M, Minakuchi M, et al. (2000) Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am J Respir Crit Care Med 162: 1518-1523. PMID: 11029371
18. Rao DR, Gaffin JM, Baxi SN, Sheehan WJ, Hoffman EB, Phinpatanakul W, et al. (2012) The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity. J Asthma 49: 586-592. doi: 10.3109/02770903.2012.690481 PMID: 22742446
19. Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, Comhair SA, et al. (2010) Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 181: 1033-1041. doi: 10.1164/rccm.200905-0695OC PMID: 20133930